Fingerprint
Dive into the research topics of 'Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma
Sally Moore*, Sangeeta Atwal, Sajitha Sachchithanantham, Matthew Streetly, Iftekhar Khan, Laura Percy, Santosh Narat, Shirley D'Sa, Neil Rabin, Rosalynd Johnston, Steve Schey, Kwee Yong
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
12
Citations
(Scopus)